BitFrontier Capital Holdings, Inc. (OTCID: BFCH), operating as UNLOCKD Inc., announced a binding Letter of Intent with NEXT10, Inc. (OTCID: NXTN) for a strategic transaction valued at $0.0004 per issued and outstanding BFCH common share. Under the agreement, NEXT10 will contribute agreed revenue-producing businesses and assets to BFCH and acquire an initial noncontrolling ownership position of up to 49%, along with representation on the BFCH Board of Directors. The agreement further provides for NEXT10 to increase its ownership to approximately 75% at a subsequent Control Closing following completion of BFCH’s planned audit and other agreed closing conditions. BFCH will remain a separately traded public company under the transaction structure.
John P. Gorst and Dr. Jordan P. Balencic will continue leading BFCH’s operating and strategic development, with NEXT10 adding Board representation, revenue-producing assets and additional organizational resources. “This is a major step forward in the strategy we began implementing at BFCH last year,” said John P. Gorst, CEO of BFCH. “NEXT10 is bringing operating assets, additional resources and a broader organization behind what we are building. The transaction significantly expands the opportunities available to BFCH while allowing our team to continue executing the strategy we have established.”
BFCH’s current portfolio includes Ancient Extracts, EVERMIND and 1ENERGY. The NEXT10 transaction is designed to expand the platform beyond individual consumer brands and create opportunities across consumer health, wellness, longevity and human optimization. The contemplated contribution is intended to add revenue-producing businesses and assets to BFCH, expanding the Company beyond its existing portfolio and accelerating its development into a broader operating platform. The transaction is consistent with management’s longer-term strategy of building BFCH into a diversified health, wellness, longevity and human optimization company capable of supporting substantially greater scale, with an ultimate objective of building toward $100 million in enterprise value.
“We see significant opportunity in what the BFCH team has been building,” said John B. Hayden, Chairman and CEO of NEXT10. “This transaction gives NEXT10 a focused platform for expanding into health, wellness, longevity and human optimization while bringing additional operating assets and resources behind an existing management team and portfolio. We believe the combination creates opportunities for both organizations that would be considerably more difficult to pursue independently.” NEXT10, through its operating platform Torreon Group, Inc., is a diversified holding and operating company focused on building value through strategic acquisitions, mergers and tangible asset development. Its businesses and investments span real estate development, affordable housing, mining, aviation, financial services and commercial enterprises in the United States and Mexico. More information is available at torreongroupinc.com.
“As a physician, I see a much larger opportunity here than simply adding more consumer brands,” said Dr. Jordan P. Balencic, Chairman and Chief Science Officer of BFCH. “Our vision is to build an integrated health, wellness, longevity and human optimization platform that can ultimately connect consumer products with technologies, testing, wellness services and scalable clinic concepts. NEXT10 gives us the opportunity to think and execute at a much greater scale.” The broader strategy is designed to create an interconnected operating platform spanning consumer products, wellness services, longevity, human optimization, technologies and scalable operating concepts, creating opportunities for businesses within the platform to share products, distribution, customers, infrastructure and operating resources.
Following the Control Closing, the parties intend to evaluate lawful structures for broader shareholder participation, including a potential future distribution of a portion of NEXT10’s BFCH holdings to eligible NEXT10 shareholders. No such distribution has been declared or approved. BFCH intends to complete its independent audit and, subject to applicable eligibility and reporting requirements, seek qualification for the OTCQB Venture Market. Additional details regarding the transaction and the executed binding agreement will be made available through the Company’s public disclosures.
The transaction could significantly impact the health and wellness industry by consolidating consumer brands with services and technologies, potentially accelerating innovation in longevity and human optimization. For readers and investors, the deal signals a strategic move toward building a larger platform with the goal of $100 million in enterprise value, though it remains subject to closing conditions.
